## Abstract ## BACKGROUND The goal of the current study was to compare the longβterm (25βmonth) safety and efficacy of zoledronic acid with pamidronate in patients with bone lesions secondary to advanced breast carcinoma or multiple myeloma. ## METHODS Patients (__n__ = 1648) were randomized to
β¦ LIBER β¦
Multiple myeloma in the breast
β Scribed by Ataga, Kenneth I.; Graham, Mark L.; Evans, Ha N.; Braeuning, Patricia; Orringer, Eugene P.
- Publisher
- John Wiley and Sons
- Year
- 1999
- Tongue
- English
- Weight
- 736 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Long-term efficacy and safety of zoledro
β
Lee S. Rosen; David Gordon; Mary Kaminski; Anthony Howell; Andrew Belch; John Ma
π
Article
π
2003
π
John Wiley and Sons
π
English
β 151 KB
π 2 views
Multiple myeloma masquerading as metasta
β
David Savage; T. J. Garrett
π
Article
π
1986
π
John Wiley and Sons
π
English
β 211 KB
π 2 views
Multiple myeloma in the liver
β
Jasjeet Kaur; Jerrold R. Turner; Parminder Singh; Ayad Al-Katib
π
Article
π
2000
π
John Wiley and Sons
π
English
β 434 KB
π 2 views
Bisphosphonates in multiple myeloma
β
John A. Kanis; Eugene V. McCloskey
π
Article
π
2000
π
John Wiley and Sons
π
English
β 277 KB
π 2 views
Pseudohyperphosphatemia in multiple myel
β
Mavrikakis, Myron; Vaiopoulos, George; Athanassiades, Peter; Antoniades, Leto; P
π
Article
π
1996
π
John Wiley and Sons
π
English
β 230 KB
π 2 views
Bisphosphonates in multiple myeloma
β
James R. Berenson
π
Article
π
1997
π
John Wiley and Sons
π
English
β 114 KB
π 2 views
bone destruction resulting in osteolytic lesions, osteoporosis, and pathologic frac-West Los Angeles Veterans Affairs Medical Centures in most patients as well as hypercalcemia and spinal cord compression in ter and the Jonsson Comprehensive Cancer many individuals. These patients frequently require